Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors
Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China
Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China
Chi-Med Announces the Approval of Fruquintinib Capsules for Previously Treated Colorectal Cancer in China
Troy Minerals Updates on Channel Sampling at Table Mountain High-Purity Silica Project, British Columbia, Canada
Standard Uranium Confirms Strong Radioactivity at Surface During Successful Exploration Program at the Rocas Uranium Project
NevGold Discovers High-Grade Oxide Antimony "Bullet Zone" From Surface with 2025 Step-Out Drilling: 14.90 g/t AuEq Over 4.6 Meters Within 2.42 g/t AuEq Over 53.3 Meters at Limo Butte, Nevada
